FWM
ARMP icon

Focused Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

Focused Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Hold
0
– – – 696
2017
Q1 		– Hold
0
– – – 685
2016
Q4 		– Sell
-11
Closed -$1.37K – 684
2016
Q3 		$24K Buy
+11
New +$2.54K 0.01% 340

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Focused Wealth Management's ARMP Position: Q2 2017 in Review

Focused Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2017 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Focused Wealth Management first reported a position in ARMP in Q3 2016 and has held it in 1 quarter since. The position peaked at $24K in Q3 2016. 11 funds tracked by Wall St. Rank hold ARMP as of Q2 2017.

  • Focused Wealth Management held 0 shares of Armata Pharmaceuticals worth $0 as of Q2 2017.
  • Focused Wealth Management left its Armata Pharmaceuticals share count unchanged in Q2 2017.
  • Armata Pharmaceuticals made up ﹤0.01% of Focused Wealth Management's portfolio in Q2 2017, its #696 holding.
  • Focused Wealth Management first reported a position in Armata Pharmaceuticals in Q3 2016 and has held it in 1 quarter since.
  • Focused Wealth Management's Armata Pharmaceuticals position peaked at $24K in Q3 2016.
  • 11 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2017.

Based on Focused Wealth Management's 13F filing for Q2 2017, filed 14 Aug 2017.